Renalytix Plc (RNLXY)

Renalytix Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 14, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	48	21	134	95	1,077	390
Market Cap Growth	-74.64%	-83.99%	40.56%	-91.14%	176.19%	90.05%
Enterprise Value	55	26	112	65	1,007	372
Last Close Price	0.26	0.23	2.92	2.45	30.86	-
PS Ratio	7.56	9.38	39.40	32.12	722.27	-
PB Ratio	-1.57	-2.73	19.24	3.12	15.07	24.50
P/TBV Ratio	-	-	19.24	3.12	15.07	24.50
EV/Sales Ratio	25.77	11.44	32.94	22.04	675.32	-
Debt / Equity Ratio	-0.73	-1.09	1.74	0.40	-	0.02
Asset Turnover	0.19	0.12	0.08	0.05	0.03	-
Quick Ratio	0.15	0.47	1.58	3.59	9.31	4.34
Current Ratio	0.24	0.53	1.67	3.80	9.46	4.51
Return on Equity (ROE)	-	-	-242.76%	-88.72%	-80.89%	-80.48%
Return on Assets (ROA)	-123.74%	-93.54%	-65.43%	-51.79%	-41.33%	-42.16%
Return on Capital (ROIC)	-501.75%	-182.66%	-85.11%	-58.23%	-46.91%	-52.16%
Earnings Yield	-97.39%	-155.90%	-34.02%	-47.47%	-3.22%	-2.52%
FCF Yield	-137.41%	-140.33%	-25.42%	-48.73%	-2.71%	-2.65%
Buyback Yield / Dilution	-27.19%	-31.59%	-11.34%	-3.29%	-21.00%	-38.81%
Total Shareholder Return	-27.19%	-31.59%	-11.34%	-3.29%	-21.00%	-38.81%

Source: S&P Capital IQ. Standard template. Financial Sources.